Cargando…

Current knowledge of targeted-release budesonide in immunoglobulin A nephropathy: A comprehensive review

Immunoglobulin A (IgA) nephropathy is a common autoimmune kidney disease. Accumulating studies showed that IgA nephropathy may be partially correlated with mucosal immune system dysfunction. Systemic corticosteroid treatment exerts an essential protective effect against renal deterioration in IgA ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jian, Zhou, Yijing, Xu, Xiuqin, Huang, Ke, Chen, Pengtao, Wu, Yuhao, Jin, Biao, Hu, Qianlong, Chen, Guanlin, Zhao, Shankun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846030/ https://www.ncbi.nlm.nih.gov/pubmed/36685528 http://dx.doi.org/10.3389/fimmu.2022.926517

Ejemplares similares

Eudragit(®) Microparticles for the Release of Budesonide: A Comparative Study
por: Cortesi, Rita, et al.
Publicado: (2012)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma
por: Morice, A H, et al.
Publicado: (2007)

Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery
por: Raval, Mihir K, et al.
Publicado: (2013)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Sucrose Nephropathy Following IV Immunoglobulin
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2010)

Chapter 10: Immunoglobulin A nephropathy
Publicado: (2012)

Significance of hyperuricemia in immunoglobulin A nephropathy
por: Nasri, Hamid, et al.
Publicado: (2013)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers
por: Suzuki, Yusuke, et al.
Publicado: (2014)

An open-label study evaluating the safety and efficacy of budesonide in patients with IgA nephropathy at high risk of progression
por: Obrișcă, Bogdan, et al.
Publicado: (2023)

Decreased frequency of adenoidectomy by a 12-week nasal budesonide treatment
por: Hong, Haiyu, et al.
Publicado: (2017)

MicroRNA-21: A Critical Pathogenic Factor of Diabetic Nephropathy
por: Liu, Shuijiao, et al.
Publicado: (2022)

The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy
por: Obara, Takashi, et al.
Publicado: (2012)

Concurrent Drug-Induced Linear Immunoglobulin A Dermatosis and Immunoglobulin A Nephropathy
por: Kim, Ji Seok, et al.
Publicado: (2015)

Idiopathic immunoglobulin A nephropathy in children and adolescents
por: Hogg, Ronald J.
Publicado: (2009)

Kartagener syndrome complicated by immunoglobulin A nephropathy
por: Oka, Kentaro, et al.
Publicado: (2018)

Immunoglobulin A Nephropathy with Erythrocytosis: An Unusual Association
por: Navaradnam, Piratheepan, et al.
Publicado: (2021)

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

Budesonide and fluticasone and adrenal suppression
por: Fouda, Mona A, et al.
Publicado: (2012)

Eosinophilic cholangitis treatment with budesonide
por: De Roza, Marianne Anastasia, et al.
Publicado: (2017)

Current knowledge on exosome biogenesis and release
por: Hessvik, Nina Pettersen, et al.
Publicado: (2017)

Budesonide-Loaded Pectin/Polyacrylamide Hydrogel for Sustained Delivery: Fabrication, Characterization and In Vitro Release Kinetics
por: Pandey, Manisha, et al.
Publicado: (2021)

Probiotic Effector Compounds: Current Knowledge and Future Perspectives
por: Daliri, Eric Banan-Mwine, et al.
Publicado: (2021)

Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy
por: Lee, Ji-Hoon, et al.
Publicado: (2016)

Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult
por: Yang, Ji Young, et al.
Publicado: (2017)

A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
por: Dong, Ruijuan, et al.
Publicado: (2020)

ODP064 Latrogenic Cushing Syndrome after Concomitant Oral Controlled-Release Budesonide and Famotidine Therapy
por: Salhah, Hiba, et al.
Publicado: (2022)

Efficacy of three different budesonide treatments in Chinese preschool children with recurrent wheezing
por: Li, Lu, et al.
Publicado: (2022)

Anti-Proteinuric Effect of Sulodexide in Immunoglobulin A Nephropathy
por: Bang, Kitae, et al.
Publicado: (2011)

Immunoglobulin A Nephropathy Associated with Plasmodium falciparum Malaria
por: Yoo, Dong Eun, et al.
Publicado: (2012)

Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)
por: De Angelis, Maria, et al.
Publicado: (2014)

Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
por: Iwasaki, Chihiro, et al.
Publicado: (2016)

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy
por: Kim, Su-Ji, et al.
Publicado: (2012)

Immunoglobulin M Nephropathy in a Patient with Wilson’s Disease
por: Ul Abideen, Zain, et al.
Publicado: (2016)

Plasma endocan level and prognosis of immunoglobulin A nephropathy
por: Lee, Yu Ho, et al.
Publicado: (2016)

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
por: Moroni, Gabriella, et al.
Publicado: (2019)

Staphylococcal infection-associated crescentic immunoglobulin A nephropathy
por: Jung, Jong Hwan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iuk9284bpnghfbgams7ppaab1l